Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-016730
Filing Date
2025-06-11
Accepted
2025-06-11 17:48:27
Documents
1
Period of Report
2025-06-09

Document Format Files

Seq Description Document Type Size
1 form4-06112025_090624.html 4  
1 form4-06112025_090624.xml 4 4178
  Complete submission text file 0001415889-25-016730.txt   5603
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Issuer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GALERA THERAPEUTICS, INC. 2 W LIBERTY BOULEVARD, #110 MALVERN PA 19355
Business Address
Bachleda Mark (Reporting) CIK: 0001887762 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40502 | Film No.: 251041074